Objective: Long periods of aortic cross-clamping time during cardiac surger
y are associated with high rates of morbidity and mortality because of dama
ge to the myocardium. Recently, we have used a method of myocardial protect
ion based on the principles of hyperkalemic cardioplegic arrest. We use ant
egrade administration of warm, undiluted blood followed by continuous retro
grade infusion of tepid, undiluted blood supplemented with potassium and ma
gnesium. In this study, we have retrospectively reviewed our experience wit
h this method of cardioprotection in operations requiring more than 2 h of
cross-clamp time. Methods: We retrospectively reviewed the medical records
of 1280 patients who underwent myocardial revascularization, valve repair o
r replacement, or a combination of both operations between January 1, 1994
and December 31, 1997. Patients were divided into two groups: the short cro
ss-clamp group (SXC) (n = 1144) had cross-clamp times <120 min (mean, 78 +/
- 20 min; range, 35-119 min) and the long cross-clamp group (LXC) (n = 136)
had cross-clamp times > 120 min (mean, 154 +/- 31 min; range, 120-277 min)
. We compared preoperative, operative, and postoperative variables between
the two groups. Results: Significantly more patients in the long cross-clam
p group (43.4%) underwent the combined operation than in the short cross-cl
amp group (2.3%), and the rate of reoperation was significantly higher in t
he long cross-clamp group (12%) than in the short cross-clamp group (5%). D
espite these differences in operative complexity, we found no difference in
hospital mortality rates between the two groups. The only significant post
operative differences were that the long cross-clamp group had a greater ne
ed for inotropic agents (43 vs. 29%), higher serum levels of creatine kinas
e (880 +/- 583 vs. 613 +/- 418) and CK-MB (10.9 +/- 6.4 vs. 5.9 +/- 5.2), a
nd a longer hospital stay (9.6 vs. 6.1 days). Conclusion: Long, complex ope
rations requiring more than 2 h of cross-clamping can be performed safely w
ith our method of cardioprotection based on continuous retrograde infusion
of tepid, hyperkalemic, undiluted blood. (C) 1999 Elsevier Science B.V. All
rights reserved.